138 related articles for article (PubMed ID: 1971033)
41. Cytomegalovirus and cervical cancer: failure to detect a direct association or an interaction with human papillomaviruses.
Thompson CH; Rose BR; Elliott PM
Gynecol Oncol; 1994 Jul; 54(1):40-6. PubMed ID: 8020838
[TBL] [Abstract][Full Text] [Related]
42. Detection and typing of human papillomavirus in cervical carcinomas in Russian women: a prognostic study.
van Muyden RC; ter Harmsel BW; Smedts FM; Hermans J; Kuijpers JC; Raikhlin NT; Petrov S; Lebedev A; Ramaekers FC; Trimbos JB; Kleter B; Quint WG
Cancer; 1999 May; 85(9):2011-6. PubMed ID: 10223243
[TBL] [Abstract][Full Text] [Related]
43. [Detection of HPV-DNA in the various uterocervical lesion by the in situ polymerase chain reaction].
Ishi K; Kina K; Koyatsu J; Kawashima T; Suzuki F; Saito A; Kubota T; Igari J
Rinsho Byori; 1997 Jan; 45(1):82-6. PubMed ID: 9022348
[TBL] [Abstract][Full Text] [Related]
44. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
45. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus genotype as a major determinant of the course of cervical cancer.
Lombard I; Vincent-Salomon A; Validire P; Zafrani B; de la Rochefordière A; Clough K; Favre M; Pouillart P; Sastre-Garau X
J Clin Oncol; 1998 Aug; 16(8):2613-9. PubMed ID: 9704710
[TBL] [Abstract][Full Text] [Related]
47. Detection of oncogenic HPV DNA by a consensus polymerase chain reaction method in genital carcinomas in twenty women in Barbados.
Prussia PR; ter Schegget J; Smits HL
West Indian Med J; 1993 Dec; 42(4):144-6. PubMed ID: 8160454
[TBL] [Abstract][Full Text] [Related]
48. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.
Walboomers JM; Jacobs MV; Manos MM; Bosch FX; Kummer JA; Shah KV; Snijders PJ; Peto J; Meijer CJ; Muñoz N
J Pathol; 1999 Sep; 189(1):12-9. PubMed ID: 10451482
[TBL] [Abstract][Full Text] [Related]
49. Human papillomavirus type distribution in cervical cancer in Delhi, India.
Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
[TBL] [Abstract][Full Text] [Related]
50. Human papillomavirus DNA in adenosquamous carcinoma and squamous cell carcinoma of the vulva.
Carson LF; Twiggs LB; Okagaki T; Clark BA; Ostrow RS; Faras AJ
Obstet Gynecol; 1988 Jul; 72(1):63-7. PubMed ID: 2837709
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus localization in cervical adenocarcinoma and adenosquamous carcinoma using in situ polymerase chain reaction: review of the literature of human papillomavirus detection in these carcinomas.
Ogura K; Ishi K; Matsumoto T; Kina K; Nojima M; Suda K
Pathol Int; 2006 Jun; 56(6):301-8. PubMed ID: 16704493
[TBL] [Abstract][Full Text] [Related]
52. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
53. Prevalence of human papillomavirus DNA in different histological subtypes of cervical adenocarcinoma.
Pirog EC; Kleter B; Olgac S; Bobkiewicz P; Lindeman J; Quint WG; Richart RM; Isacson C
Am J Pathol; 2000 Oct; 157(4):1055-62. PubMed ID: 11021808
[TBL] [Abstract][Full Text] [Related]
54. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
55. The role of p53 inactivation in human cervical cell carcinoma development.
Miwa K; Miyamoto S; Kato H; Imamura T; Nishida M; Yoshikawa Y; Nagata Y; Wake N
Br J Cancer; 1995 Feb; 71(2):219-26. PubMed ID: 7841033
[TBL] [Abstract][Full Text] [Related]
56. [Detection of HPV-DNA in the various uterocervical lesions by in situ hybridization].
Ishi K; Kina K; Kawashima T; Shimota H; Utsuno H; Takada M
Rinsho Byori; 1989 Nov; 37(11):1284-8. PubMed ID: 2557468
[TBL] [Abstract][Full Text] [Related]
57. DNA sequences of human papillomavirus types 11, 16 or 18 in invasive cervical carcinoma of Western Australian women.
Kulski JK; Howard MJ; Pixley EC
Immunol Cell Biol; 1987 Feb; 65 ( Pt 1)():77-84. PubMed ID: 3038735
[TBL] [Abstract][Full Text] [Related]
58. [Virological studies on generation of cervical carcinomas].
Yoshikawa H
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):834-43. PubMed ID: 2172420
[TBL] [Abstract][Full Text] [Related]
59. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
60. Demonstration of multiple HPV types in normal cervix and in cervical squamous cell carcinoma using the polymerase chain reaction on paraffin wax embedded material.
Griffin NR; Bevan IS; Lewis FA; Wells M; Young LS
J Clin Pathol; 1990 Jan; 43(1):52-6. PubMed ID: 2155946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
